Proteomic analysis of saliva: A unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes

Arthritis Research and Therapy

Volumn 13, Issue 6, 2011, Pages

  Baldini, Chiara ^a   Giusti, Laura ^a   Ciregia, Federica ^a   Da Valle, Ylenia ^a   Giacomelli, Camillo ^a   Donadio, Elena ^a   Sernissi, Francesca ^a   Bazzichi, Laura ^a   Giannaccini, Gino ^a   Bombardieri, Stefano ^a   Lucacchini, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Primary sj gren's syndrome; Proteomics; Secondary sj gren's syndrome; Whole saliva

Indexed keywords

AMYLASE; BETA 2 MICROGLOBULIN; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE VI; ENZYME PRECURSOR; FATTY ACID BINDING PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN KAPPA CHAIN; UNCLASSIFIED DRUG; ENOLASE; IMMUNOGLOBULIN LIGHT CHAIN; PROTEOME;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; KNOWLEDGE BASE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RHEUMATOID ARTHRITIS; SALIVA ANALYSIS; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS; TWO DIMENSIONAL ELECTROPHORESIS; VALIDATION PROCESS; WESTERN BLOTTING; AGED; BIOLOGICAL MODEL; CASE CONTROL STUDY; CLUSTER ANALYSIS; DIFFERENTIAL DIAGNOSIS; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; SALIVA; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; ALPHA-AMYLASES; ARTHRITIS, RHEUMATOID; BETA 2-MICROGLOBULIN; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; DIAGNOSIS, DIFFERENTIAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; MIDDLE AGED; MODELS, BIOLOGICAL; PHOSPHOPYRUVATE HYDRATASE; PRINCIPAL COMPONENT ANALYSIS; PROTEOME; PROTEOMICS; SALIVA; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 82055164016     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3523     Document Type: Article

References (35)

1. Papiris SA, Tsonis IA, Moutsopoulos HM. Sjögren's syndrome. Semin Respir Crit Care Med 2007, 28:459-471. 10.1055/s-2007-985667, 17764063.
2. Haldorsen K, Moen K, Jacobsen H, Jonsson R, Brun JG. Exocrine function in primary Sjögren syndrome: natural course and prognostic factors. Ann Rheum Dis 2008, 67:949-954.
3. Fietta P, Delsante G, Quaini F. Hematologic manifestations of connective autoimmune diseases. Clin Exp Rheumatol 2009, 27:140-154.
4. Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Mortality in Sjögren's syndrome. Clin Exp Rheumatol 2008, 26:S66-71.
5. Ng WF, Bowman SJ. Primary Sjogren's syndrome: too dry and too tired. Rheumatology (Oxford) 2010, 49:844-853.
6. Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, Bootsma H. Health-related quality of life, employment and disability in patients with Sjogren's syndrome. Rheumatology (Oxford) 2009, 48:1077-1082.
7. Hernández-Molina G, Avila-Casado C, Cárdenas-Velázquez F, Hernández-Hernández C, Calderillo ML, Marroquín V, Soto-Abraham V, Recillas-Gispert C, Sánchez-Guerrero J. Similarities and differences between primary and secondary Sjögren's syndrome. J Rheumatol 2010, 37:800-808. 10.3899/jrheum.090866, 20194453.
8. Voulgarelis M, Moutsopoulos HM. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis. Rheum Dis Clin North Am 2008, 34:921-933. viii, 10.1016/j.rdc.2008.08.006, 18984412.
9. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, . European Study Group on Classification Criteria for Sjögren's Syndrome Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558. 10.1136/ard.61.6.554, 1754137, 12006334, European Study Group on Classification Criteria for Sjögren's Syndrome.
10. Ramos-Casals M, Brito-Zerón P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A, Soto MJ, Akasbi M, Diaz C, Sentís J, Siso A. Sjögren syndrome or Sjögren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 2010, 38:178-185. 10.1007/s12016-009-8152-z, 19578996.
11. Giusti L, Baldini C, Bazzichi L, Bombardieri S, Lucacchini A. Proteomic diagnosis of Sjögren's syndrome. Expert Rev Proteomics 2007, 4:757-767. 10.1586/14789450.4.6.757, 18067414.
12. Giusti L, Baldini C, Bazzichi L, Ciregia F, Tonazzini I, Mascia G, Giannaccini G, Bombardieri S, Lucacchini A. Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome. Proteomics 2007, 7:1634-1643. 10.1002/pmic.200600783, 17436266.
13. Ryu OH, Atkinson JC, Hoehn GT, Illei GG, Hart TC. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford) 2006, 45:1077-1086.
14. Peluso G, De Santis M, Inzitari R, Fanali C, Cabras T, Messana I, Castagnola M, Ferraccioli GF. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum 2007, 56:2216-2222. 10.1002/art.22738, 17599740.
15. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, Zhou H, Henry S, Vissink A, Pijpe J, Kallenberg C, Elashoff D, Loo JA, Wong DT. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum 2007, 56:3588-3600. 10.1002/art.22954, 2856841, 17968930.
16. Fleissig Y, Deutsch O, Reichenberg E, Redlich M, Zaks B, Palmon A, Aframian DJ. Different proteomic protein patterns in saliva of Sjögren's syndrome patients. Oral Dis 2009, 15:61-68. 10.1111/j.1601-0825.2008.01465.x, 18939961.
17. Hu S, Gao K, Pollard R, Arellano-Garcia M, Zhou H, Zhang L, Elashoff D, Kallenberg CG, Vissink A, Wong DT. Preclinical validation of salivary biomarkers for primary Sjögren's syndrome. Arthritis Care Res 2010, 62:1633-1638.
18. Hochstrasser DF, Patchornik A, Merril CR. Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal Biochem 1988, 173:412-423. 10.1016/0003-2697(88)90208-4, 3189819.
19. Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B, Orecchia P, Zardi L, Righetti PG. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25:1327-1333. 10.1002/elps.200305844, 15174055.
20. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567. 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2, 10612281.
21. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392. 10.1021/ac025747h, 12403597.
22. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658. 10.1021/ac0341261, 14632076.
23. Yan JX, Wait R, Berkelman T, Harry RA, Westbrook JA, Wheeler CH, et al. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21:3666-3. Youinou P, Taher TE, Pers JO, Mageed RA, Renaudineau Y: B lymphocyte cytokines and rheumatic autoimmune disease. Arthritis Rheum 2009, 60:1873-1880., 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6, 11271485.
24. Anderson LG, Cummings NA, Asofsky R, Hylton MB, Tarpley TM, Tomasi TB, Wolf RO, Schall GL, Talal N. Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Natural history and response to treatment. Am J Med 1972, 53:456-463. 10.1016/0002-9343(72)90141-6, 4627721.
25. Gottenberg JE, Busson M, Cohen-Solal J, Lavie F, Abbed K, Kimberly RP, Sibilia J, Mariette X. Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome. Ann Rheum Dis 2005, 64:1050-1055. 10.1136/ard.2004.030643, 1755548, 15640273.
26. Giusti L, Baldini C, Ciregia F, Giannaccini G, Giacomelli C, De Feo F, Delle Sedie A, Riente L, Lucacchini A, Bazzichi L, Bombardieri S. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis?. Proteomics Clin Appl 2010, 4:315-324. 10.1002/prca.200900082, 21137052.
27. de Seny D, Fillet M, Ribbens C, Marée R, Meuwis MA, Lutteri L, Chapelle JP, Wehenkel L, Louis E, Merville MP, Malaise M. Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clin Chem 2008, 54:1066-1075. 10.1373/clinchem.2007.099549, 18436720.
28. Giusti L, Bazzichi L, Baldini C, Ciregia F, Mascia G, Giannaccini G, Del Rosso M, Bombardieri S, Lucacchini A. Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J Rheumatol 2007, 34:2063-2069.
29. Nikolov NP, Illei GG. Pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol 2009, 21:465-470. 10.1097/BOR.0b013e32832eba21, 2766246, 19568172.
30. Nordmark G, Alm GV, Rönnblom L. Mechanisms of disease: primary Sjögren's syndrome and the type I interferon system. Nat Clin Pract Rheumatol 2006, 2:262-269. 10.1038/ncprheum0173, 16932699.
31. Delaleu N, Jonsson MV, Appel S, Jonsson R. New concepts in the pathogenesis of Sjögren's syndrome. Rheum Dis Clin North Am 2008, 34:833-845. vii, 10.1016/j.rdc.2008.08.004, 18984407.
32. Gottenberg JE. Primary Sjögren's syndrome: pathophysiological, clinical and therapeutic advances. Joint Bone Spine 2009, 76:591-594. 10.1016/j.jbspin.2009.09.006, 19932634.
33. Szodoray P, Papp G, Horvath IF, Barath S, Sipka S, Nakken B, Zeher M. Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome. Clin Exp Immunol 2009, 157:343-349. 10.1111/j.1365-2249.2009.03966.x, 2745027, 19664141.
34. Zheng L, Zhang Z, Yu C, Tu L, Zhong L, Yang C. Association between IFN-α and primary Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107:e12-18.
35. Roescher N, Tak PP, Illei GG. Cytokines in Sjogren's syndrome: potential therapeutic targets. Ann Rheum Dis 2010, 69:945-948. 10.1136/ard.2009.115378, 3044243, 20410069.